1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NEWAMSTERDAM PHARMA COMPANY NV
NewAmsterdam Pharma Company NV XNAS: NAMS
38.97 2.21 (6.01%)
2.0M
XNAS Volume

XNAS 10 Nov, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert

Board Meeting
The next board meeting for NewAmsterdam Pharma Company NV is on 19 Nov 2025 for the purpose of Jefferies London Healthcare Conference 2025 See details

NewAmsterdam Pharma Company NV quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents